LATEST MANUSCRIPTS IN Therapeutic Advances in Drug Safety
Nokuthula L Makhene, Hanlie Steyn, Martine Vorster, Martie S Lubbe, Johanita R Burger. Development of a checklist for the assessment of pharmacovigilance guidelines in Southern Africa: a document review.Therapeutic advances in drug safety. 2023, 14: 20420986221143272
Marie-Celine Haker, Niklas Frahm, Michael Hecker, Silvan Elias Langhorst, Pegah Mashhadiakbar, Jane Louisa Debus, Barbara Streckenbach, Julia Baldt, Felicita Heidler, Uwe Klaus Zettl. Therapy of women with multiple sclerosis: an analysis of the use of drugs that may have adverse effects on the unborn child in the event of (unplanned) pregnancy.Therapeutic advances in drug safety. 2023, 14: 20420986221143830
Fiona Robinson, Sonji Wilkes, Nathan Schaefer, Miriam Goldstein, Michelle Rice, Johanna Gray, Sharon Meyers, Leonard A Valentino. Patient-centered pharmacovigilance: priority actions from the inherited bleeding disorders community.Therapeutic advances in drug safety. 2023, 14: 20420986221146418
Ali F Altebainawi, Lulwa A Alfaraj, Amjad A Alharbi, Fadwa F Alkhuraisi, Thamir M Alshammari. Association between proton pump inhibitors and rhabdomyolysis risk: a post-marketing surveillance using FDA adverse event reporting system (FAERS) database.Therapeutic advances in drug safety. 2023, 14: 20420986231154075
Fatema A Alqenae, Douglas Steinke, Andrew Carson-Stevens, Richard N Keers. Analysis of the nature and contributory factors of medication safety incidents following hospital discharge using National Reporting and Learning System (NRLS) data from England and Wales: a multi-method study.Therapeutic advances in drug safety. 2023, 14: 20420986231154365
Charlotte Arp Sørensen, Linda Jeffery, Jannik Falhof, Philipp Harbig, Klaus Roelsgaard, Solveig Gram, Charlotte Olesen. Developing and piloting a cross-sectoral hospital pharmacist intervention for patients in transition between hospital and general practice.Therapeutic advances in drug safety. 2023, 14: 20420986231159221
Heyde-Patricia Zuluaga-Arias, Mayada Alkhakany, Manal M Younus, Houda Sefiani, Angela Caro-Rojas, Sameh Al-Zubiedi, Wafi F Albalawi, Thamir M Alshammari. Impact of risk communication on patient's safety during the pandemic.Therapeutic advances in drug safety. 2023, 14: 20420986231159752
Sara Eslait-Olaciregui, Kevin Llinás-Caballero, David Patiño-Manjarrés, Thomas Urbina-Ariza, Juan Fernando Cediel-Becerra, Camilo Alberto Domínguez-Domínguez. Serious neurological adverse events following immunization against SARS-CoV-2: a narrative review of the literature.Therapeutic advances in drug safety. 2023, 14: 20420986231165674
Yang Lu, Caiyun Guo. Risk of lower limb amputation in diabetic patients using SGLT2 inhibitors DPP4 inhibitors or GLP-1 agonists: a meta-analysis of 2 million patients.Therapeutic advances in drug safety. 2023, 14: 20420986231178126
Britney A Stottlemyer, Michael C McDermott, Mackenzie R Minogue, Matthew P Gray, Richard D Boyce, Sandra L Kane-Gill. Assessing adverse drug reaction reports for antidiabetic medications approved by the food and drug administration between 2012 and 2017: a pharmacovigilance study.Therapeutic advances in drug safety. 2023, 14: 20420986231181334
Ivana Damnjanović, Nastia Tsyplakova, Nikola Stefanović, Tatjana Tošić, Aleksandra Catić-Đorđević, Vangelis Karalis. Joint use of population pharmacokinetics and machine learning for optimizing antiepileptic treatment in pediatric population.Therapeutic advances in drug safety. 2023, 14: 20420986231181337
Hui-Hsia Hsieh, Tien-Yuan Wu, Chi-Hua Chen, Yu-Hung Kuo, Mann-Jen Hour. Survival outcomes of beta-blocker usage in HER2-positive advanced breast cancer patients: a retrospective cohort study.Therapeutic advances in drug safety. 2023, 14: 20420986231181338
Opeyemi Atanda, Jonathan West, Tom Stables, Chris Johnson, Robert Merrifield, James Kinross. Flow rate accuracy of infusion devices within healthcare settings: a systematic review.Therapeutic advances in drug safety. 2023, 14: 20420986231188602